These results position Epitalon as a potential candidate for stabilizing cholinergic tone, a critical early disruption in age-related cognitive decline, and for addressing cognitive disorders associated with cholinergic deficiency and amyloid metabolism
During the initial phase, patients who experience symptoms of fatigue, low mood, or nutrient deficiency may notice a gradual improvement after the first few sessions
USF1 and USF2, but not c-Myc, can bind to this E-box and overexpression of either one can inhibit the promoter activity (Cheng et al., 2005)
Preclinical studies have explored its potential effects on the gastrointestinal tract, muscles, ligaments, tendons, and nerves